| Literature DB >> 30728941 |
Abstract
Diabetes technologies are an unstoppable phenomenon. They offer opportunities to improve patient self-care through empowerment. However, they can be a challenge for both patients and clinicians. Thus, the use of technology may empower or burden. To understand and benefit from the use of diabetes technologies, one must understand the currently unmet needs in diabetes management. These unmet needs call for perspectives beyond glycated hemoglobin and an evaluation of technology solutions. Optimal use of these technologies is necessary to obtain benefits and achieve cost-effectiveness; this process depends on diabetes education and training. This review evaluates clinician and patient perspectives regarding diabetes technologies, followed by an evaluation of technology solutions. Diabetes technology solutions are evaluated according to available results about their effectiveness and their potential to empower people living with diabetes.Entities:
Keywords: biomedical technology; diabetes mellitus; patient participation; self-care; therapy
Year: 2019 PMID: 30728941 PMCID: PMC6351708 DOI: 10.1177/2042018818824215
Source DB: PubMed Journal: Ther Adv Endocrinol Metab ISSN: 2042-0188 Impact factor: 3.565